文献速递胃肠动力与功能性疾病

肠道真菌失调与肠易激综合征患者及大鼠的内脏高敏感相关

Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
PubMed 文献 · Gastroenterology · 2017-06-15

研究比较18名健康志愿者与39例肠易激综合征(IBS)患者(含内脏高敏感与正常敏感者)的粪便真菌组,并比较母婴分离(高敏感)与非处理(正常敏感)Long-Evans大鼠的真菌组。结果显示两组IBS患者α多样性(Shannon指数)及真菌组特征均与健康志愿者不同,高敏感患者真菌组特征亦不同于正常敏感患者;大鼠中母婴分离者存在真菌失调,抗真菌药可使高敏感大鼠的内脏高敏感降至正常敏感水平,而移植母婴分离大鼠盲肠真菌组可恢复高敏感,可溶性β-葡聚糖或SYK抑制剂可减轻内脏高敏感,颗粒性β-葡聚糖(DECTIN-1激动剂)可诱导肠系膜窗肥大细胞脱颗粒,HMC-1细胞对真菌抗原应答释放组胺。

要点

  • IBS患者(含高敏感与正常敏感者)粪便真菌α多样性(Shannon指数)及真菌组特征均与健康志愿者不同。
  • 母婴分离高敏感大鼠存在真菌失调,抗真菌药可将其内脏高敏感降至正常敏感水平。
  • 可溶性β-葡聚糖或SYK抑制剂可减轻大鼠内脏高敏感,颗粒性β-葡聚糖可诱导肥大细胞脱颗粒。

核心结论

  • 在IBS患者与对照分析中,真菌失调与IBS相关;大鼠研究中真菌可促进内脏高敏感,抗真菌药、可溶性β-葡聚糖或SYK抑制剂可减轻之。
  • 肠道真菌或可被操控用于治疗IBS相关内脏高敏感。

研究设计与样本

  • 比较18名健康志愿者与39例IBS患者(含内脏高敏感或正常敏感水平者)的粪便真菌组,采用基于内转录间隔区1的宏条形码技术。
  • 比较母婴分离(高敏感)Long-Evans大鼠与非处理(正常敏感)大鼠的真菌组。
  • 用暴露于抗真菌药(氟康唑和制霉菌素)的大鼠研究真菌能否引起内脏高敏感。
  • 粪便移植实验:对成年母婴分离大鼠施加避水应激(诱导内脏高敏感),再经口灌胃给予抗真菌药及供体盲肠内容物。
  • 其他避水应激大鼠给予可溶性β-葡聚糖(经脾相关酪氨酸激酶SYK拮抗C型凝集素结构域家族7成员A即CLEC7A或DECTIN1信号)、SYK抑制剂以减轻内脏高敏感,或给予溶媒(对照)。

主要发现

  • 两组IBS患者的α多样性(Shannon指数)及真菌组特征(稳定性选择)均与健康志愿者不同,高敏感患者真菌组特征与正常敏感患者不同。
  • 母婴分离大鼠较非处理大鼠出现真菌失调。
  • 给予高敏感大鼠抗真菌药可将其内脏高敏感降至正常敏感水平。
  • 给予母婴分离大鼠盲肠真菌组(而非非处理大鼠真菌组)可恢复对扩张的高敏感。
  • 与对照相比,给予可溶性β-葡聚糖或SYK抑制剂可减轻内脏高敏感。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Visceral hypersensitivity is one feature of irritable bowel syndrome (IBS). Bacterial dysbiosis might be involved in the activation of nociceptive sensory pathways, but there have been few studies of the role of the mycobiome (the fungal microbiome) in the development of IBS. We analyzed intestinal mycobiomes of patients with IBS and a rat model of visceral hypersensitivity. METHODS: We used internal transcribed spacer 1-based metabarcoding to compare fecal mycobiomes of 18 healthy volunteers with those of 39 patients with IBS (with visceral hypersensitivity or normal levels of sensitivity). We also compared the mycobiomes of Long-Evans rats separated from their mothers (hypersensitive) with non-handled (normally sensitive) rats. We investigated whether fungi can cause visceral hypersensitivity using rats exposed to fungicide (fluconazole and nystatin). The functional relevance of the gut mycobiome was confirmed in fecal transplantation experiments: adult maternally separated rats were subjected to water avoidance stress (to induce visceral hypersensitivity), then given fungicide and donor cecum content via oral gavage. Other rats subjected to water avoidance stress were given soluble β-glucans, which antagonize C-type lectin domain family 7 member A (CLEC7A or DECTIN1) signaling via spleen-associated tyrosine kinase (SYK), a SYK inhibitor to reduce visceral hypersensitivity, or vehicle (control). The sensitivity of mast cells to fungi was tested with mesenteric windows (ex vivo) and the human mast cell line HMC-1. RESULTS: α diversity (Shannon index) and mycobiome signature (stability selection) of both groups of IBS patients differed from healthy volunteers, and the mycobiome signature of hypersensitive patients differed from that of normally sensitive patients. We observed mycobiome dysbiosis in rats that had been separated from their mothers compared with non-handled rats. Administration of fungicide to hypersensitive rats reduced their visceral hypersensitivity to normal levels of sensitivity. Administration of cecal mycobiomes from rats that had been separated from their mothers (but not non-handled mycobiome) restored hypersensitivity to distension. Administration of soluble β-glucans or a SYK inhibitor reduced visceral hypersensitivity, compared with controls. Particulate β-glucan (a DECTIN-1 agonist) induced mast cell degranulation in mesenteric windows and HMC-1 cells responded to fungal antigens by release of histamine. CONCLUSIONS: In an analysis of patients with IBS and controls, we associated fungal dysbiosis with IBS. In studies of rats, we found fungi to promote visceral hypersensitivity, which could be reduced by administration of fungicides, soluble β-glucans, or a SYK inhibitor. The intestinal fungi might therefore be manipulated for treatment of IBS-related visceral hypersensitivity.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Botschuijver S, Roeselers G, Levin E, et al. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats. Gastroenterology. 2017. PMID: 28624575. doi:10.1053/j.gastro.2017.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。